APA (7th ed.) Citation

ST, P., MM, P., I, R., G, H., L, W., AM, D., & B, T. (2022). Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on the Cystic Fibrosis Airway Microbial Metagenome. Microbiology spectrum, 10(5), e0145422. https://doi.org/10.1128/spectrum.01454-22

Chicago Style (17th ed.) Citation

ST, Pallenberg, Pust MM, Rosenboom I, Hansen G, Wiehlmann L, Dittrich AM, and Tümmler B. "Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on the Cystic Fibrosis Airway Microbial Metagenome." Microbiology Spectrum 10, no. 5 (2022): e0145422. https://doi.org/10.1128/spectrum.01454-22.

MLA (9th ed.) Citation

ST, Pallenberg, et al. "Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on the Cystic Fibrosis Airway Microbial Metagenome." Microbiology Spectrum, vol. 10, no. 5, 2022, p. e0145422, https://doi.org/10.1128/spectrum.01454-22.